Status:
COMPLETED
Genetic Modifiers for 22q11.2 Syndrome
Lead Sponsor:
State University of New York - Upstate Medical University
Collaborating Sponsors:
Albert Einstein College of Medicine
Conditions:
22q11.2 Deletion Syndrome
Eligibility:
All Genders
Brief Summary
The purpose of the project is the determination of how the deletion of DNA from chromosome 22 at the q11.2 band causes the phenotypes observed in velo-cardio-facial syndrome (VCFS). In other words, th...
Eligibility Criteria
Inclusion
- FISH confirmed diagnosis of 22q11.2 deletion syndrome
Exclusion
- none
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
End Date :
February 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00916955
Start Date
March 1 2008
End Date
February 1 2015
Last Update
October 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
VCFS International Center
Syracuse, New York, United States, 13210